BioSpace News Archive

During the ASPC annual business meeting during the recent 2020 ASPC Virtual Summit on CVD Prevention, Peter P. Toth, MD, PhD, FASPC was officially elected as the President of the American Society for Preventive Cardiology (ASPC).

Results from genomic testing of a cancer patient’s biopsy tissue can help guide treatment decisions, depending on the types of gene mutations found. But as it spreads or stops responding to treatment, the cancer changes and develops new mutations. Insights gained from the biopsy of the primary tumor may no longer be relevant in determining next steps.

Third FDA-Approved Therapy in Just Over a Year for Neuromyelitis Optica Spectrum Disorder Gives Patients Another Treatment Option

Illinois Bone & Joint Institute (IBJI), the largest independent, physician-owned orthopedic practice in Illinois, welcomes Orthopaedic Surgery Specialists (OSS) to our practice as of August 1, 2020

Probo Medical (“Probo”), a leading provider of medical imaging equipment, parts, repair and service, announced today it was ranked 649 by Inc. magazine as one of the nation’s fastest growing private companies 2020.

Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator.

Tango Therapeutics, a biotechnology company focused on discovering and delivering the next generation of targeted cancer therapies, today announced the closing of $50 million in equity financing.

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the second quarter of 2020.

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced that the Journal of Clinical Oncology has published results from its Phase 1 study of QINLOCK, the Company’s switch-control tyrosine kinase inhibitor, in patients with second-line through fourth-line plus gastrointestinal stromal tumor (GIST).

The demand within the global arthroscopy devices market is set to increase by a dramatic chase in the times to follow.